Skip to content
MARKETS / NASDAQ / TALK
NASDAQ · SERVICES-HEALTH SERVICES · MID CAP

Talkspace, Inc. TALK

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$228.9M
▲ 22.0% YoY
$7.8M
▲ 578.8% YoY
In brief

What this company does

Talkspace, Inc. offers its members access to a network of providers through virtual psychotherapy and psychiatry. As of December 31, 2025, it had 598 employees, comprised of 349 providers and 249 professionals supporting accounting, finance, technology, sales, marketing and other support functions, along with 5,396 independently contracted providers. Its network includes more than 5,700 licensed providers located across all 50 U.S. states and the District of Columbia, with specialized knowledge of more than 150 conditions and treatment modalities. Its customers are organized into three categories: Payor, comprising health insurance plans from commercial and government institutions and employee assistance programs; Direct-to-Enterprise (DTE), comprising enterprises under an active contract with Talkspace; and Consumer, comprising individual subscribers. Under Payor, it contracts with health insurance plans from commercial and government institutions and employee assistance programs to provide virtual therapy to their members, who receive care through their health insurance plan or employee assistance program or pay a flat rate per session or interaction. Under DTE, it contracts directly with enterprises, including employers, academic organizations, higher education, and government entities, to provide their enterprise members unlimited synchronous and asynchronous care on a per-member-per-month or paid-per-use basis or as a fixed monthly fee. Under Consumer, it offers monthly, quarterly, bi-annual and annual membership subscriptions, as well as supplementary a la carte offerings, to individual subscribers who subscribe directly to its platform. Talkspace was founded in 2012.

Written from the business description in Talkspace, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 13 March 2026. Every sentence was checked against that document before publication.

Growth
USD 228.9M
Revenue, FY2025 · full 7-year series below
Revenue $M Net income $M
FY2025 · Revenue 228.9 · Net income 7.8
80M160M-40M2019202020212022202320242025
Compound annual growth
+24.2%
+24.6%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +24.6% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
3 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 1.4% · Net 3.4%
-50%2019202020212022202320242025
ROE
FY2025 · ROE 6.6%
-50%-100%2019202020212022202320242025

Each USD of equity produced 7 cents of profit this year.

Cash & shareholders
USD 16.3M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2023 · FCF -16.5
-25.0M-50.0M2019202020212022202320242025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 16.3
8M16M-2M2022202320242025

USD 16.3M in buybacks — 209% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 134.9M
EquityUSD 117.0M
CashUSD 37.4M
Current ratio6.38×

Equity funds 87% of total assets.

The 7-year record
7 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019
Revenue $B0.20.20.20.10.10.10.0
Operating income $B0.0−0.0−0.0−0.1−0.1−0.0−0.0
EBITDA $B0.0−0.0−0.0−0.1−0.1−0.0−0.0
Income tax $B0.00.00.00.00.00.00.0
Net income $B0.00.0−0.0−0.1−0.1−0.0−0.0
Free cash flow $B··−0.0−0.1−0.1−0.0−0.0
EPS, diluted $0.040.01−0.12−0.51−0.72−1.67−2.29
Dividend / sh $·······
Payout %·······
ROE %6.61.0−15.6−49.8−134.4··
Shares out B0.170.170.170.160.150.01·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 32 reconciliationsAUDITED

Reconciled in 7 of 19 fiscal years. 63 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Health Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2019

Share this section

Download image